SEARCH

SEARCH BY CITATION

References

  • 1
    Hoffmeister RT: Methotrexate in rheumatoid arthritis (abstract). Arthritis Rheum 15: 114, 1972
  • 2
    Hoffmeister RT: Methotrexate therapy in rheumatoid arthritis: 15 years experience. Am J Med 75: 6973, 1983
  • 3
    Willkens RF, Watson MA: Methotrexate: a perspective of its use in the treatment of rheumatic diseases. J Lab Clin Med 100: 314321, 1982
  • 4
    Steinsson K, Weinstein A, Korn J, Abeles M: Low dose methotrexate in rheumatoid arthritis. J Rheumatol 9: 860866, 1982
  • 5
    Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE: Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312: 818822, 1985
  • 6
    Williams HJ, Willkens RF, Samuelson CO Jr, Alarcón GS, Guttadauria M, Yarboro C, Polisson RP, Weiner SR, Luggen ME, Billingsley LM, Dahl SL, Egger MJ, Reading JC, Ward JR: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 28: 721730, 1985
  • 7
    Thompson RN, Watts C, Edelman J, Esdaile J, Russell AS: A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol 11: 760763, 1984
  • 8
    Andersen PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL: Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med 103: 489496, 1985
  • 9
    Hamdy H, McKendry RJR, Mierins E, Liver JA: Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a twenty-four–week controlled clinical trial. Arthritis Rheum 30: 361368, 1987
  • 10
    Arnold MH, O'Callaghan J, McCredie M, Beller EM, Kelly DE, Brooks PM: Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study. Br J Rheumatol 29: 120125, 1990
  • 11
    Morassut P, Goldstein R, Cyr M, Karsh J, McKendry RJ: Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis: a randomized, double blind 26-week trial. J Rheumatol 16: 302306, 1989
  • 12
    Suarez-Almazor ME, Fitzgerald A, Grace M, Russell AS: A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis. J Rheumatol 15: 753756, 1988
  • 13
    Weinblatt ME, Kaplan H, Germain BF, Merriman RC, Solomon SD, Wall B, Anderson L, Block S, Irby R, Wolfe F, Gall E, Torretti D, Biundo J, Small R, Coblyn J, Polisson R: Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis: a thirty-six–week, double-blind trial. Arthritis Rheum 33: 330338, 1990
  • 14
    Rau R, Herborn G, Karger T, Menninger H, Elhardt D, Schmitt J: A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. J Rheumatol 18: 328333, 1991
  • 15
    Jeurissen MEC, Boerbooms AMT, van de Putte LBA, Doesburg WH, Mulder J, Rasker JJ, Kruijsen MWM, Haverman JF, van Beusekom HJ, Muller WH, Franssen MJAM, de Rooy D-JRAM: Methotrexate versus azathioprine in the treatment of rheumatoid arthritis: a forty-eight–week randomized, doubleblind trial. Arthritis Rheum 34: 961972, 1991
  • 16
    Kremer JM, Lee JK: The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 29: 822831, 1986
  • 17
    Kremer JM, Lee JK: A long-term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of fifty-three months. Arthritis Rheum 31: 577584, 1988
  • 18
    Kremer JM, Phelps CT: Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: update after a mean of 90 months. Arthritis Rheum 35: 138145, 1992
  • 19
    Weinblatt ME, Kaplan H, Germain BF, Merriman RC, Solomon SD, Wall B, Anderson L, Block S, Small R, Wolfe F, Gall E, Torretti D, Polisson R: Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study. J Rheumatol 18: 334338, 1991
  • 20
    Hanrahan PS, Scrivens GA, Russell AS: Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol 28: 147153, 1989
  • 21
    Weinblatt ME, Trentham DE, Fraser PA, Holdsworth DE, Falchuk KR, Weissman BN, Coblyn JS: Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 31: 167175, 1988
  • 22
    Weinblatt ME, Weissman BN, Holdsworth DE, Fraser PA, Maier AL, Falchuk KR, Coblyn JS: Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84-month update. Arthritis Rheum 35: 129137, 1992
  • 23
    Wolfe F, Hawley DJ, Cathey MA: Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 17: 9941002, 1990
  • 24
    Alarcón GS, Tracy IC, Blackburn WD Jr: Methotrexate in rheumatoid arthritis: toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 32: 671676, 1989
  • 25
    Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein GD: Methotrexate guidelines: revised. J Am Acad Dermatol 6: 145155, 1982
  • 26
    Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein GD: Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol 19: 145156, 1988
  • 27
    Health and Public Policy Committee, American College of Physicians: Methotrexate in rheumatoid arthritis. Ann Intern Med 107: 418419, 1987
  • 28
    Furst DE, Kremer JM: Methotrexate in rheumatoid arthritis. Arthritis Rheum 31: 305314, 1988
  • 29
    Bridges SL Jr, Alarcón GS, Koopman WJ: Methotrexateinduced liver abnormalities in rheumatoid arthritis. J Rheumatol 16: 11801183, 1989
  • 30
    Kremer JM: Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going? J Rheumatol 19: 189191, 1992
  • 31
    Furst DE, Erikson N, Clute L, Koehnke R, Burmeister LF, Kohler JA: Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis. J Rheumatol 17: 16281635, 1990
  • 32
    Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I: Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 16: 313320, 1989
  • 33
    Galen RS, Gambino SR: Beyond Normality: The Predictive Value and Efficiency of Medical Diagnoses. New York, Wiley, 1975
  • 34
    Tolman KG, Kremer J, Lee RG, Mitros F, LaBrecque DE, Furst DE: Pretreatment liver histology in rheumatoid arthritis patients treated with low dose methotrexate (abstract). Arthritis Rheum 29 (suppl 4): S18, 1986
  • 35
    Kremer JM, Lee RG, Tolman KG: Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy: a prospective study with baseline and sequential biopsy samples. Arthritis Rheum 32: 121127, 1989
  • 36
    Kremer JM, Tolman KG, Lee RG: Baseline and follow-up liver histology in rheumatoid arthritis patients receiving pulse methotrexate (abstract). Arthritis Rheum 30 (suppl 4): S17, 1987
  • 37
    Boh LE, Schuna AA, Pitterle ME, Adams EM, Sundstrom WR: Low-dose weekly oral methotrexate therapy for inflammatory arthritis. Clin Pharm 5: 503508, 1986
  • 38
    Brick JE, Moreland LW, Al-Kawas F, Chang WW, Layne RD, DiBartolomeo AG: Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients. Semin Arthritis Rheum 19: 3144, 1989
  • 39
    Rau R, Karger T, Herborn G, Frenzel H: Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate. J Rheumatol 16: 489493, 1989
  • 40
    Koo AP, MacKenzie AH, Tuthill RJ, Leatherman JR: Liver histology in rheumatoid arthritis before and after prolonged methotrexate therapy (abstract). Arthritis Rheum 28 (suppl 4): S14, 1985
  • 41
    Phillips CA, Cera PJ, Mangan TF, Newman ED: Clinical liver disease in patients with rheumatoid arthritis taking methotrexate. J Rheumatol 19: 229233, 1992
  • 42
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach J, The Sentinel Counties Chronic Non-A Non-B Hepatitis Study Team: The natural history of community acquired hepatitis C in the United States. N Engl J Med 327: 18991905, 1992
  • 43
    Anderson MG, Murray-Lyon IM: Progress report natural history of the HBsAg carrier. Gut 26: 848860, 1985
  • 44
    Weinstein A, Marlowe S, Korn J, Farouhar F: Low-dose methotrexate treatment of rheumatoid arthritis: long-term observations. Am J Med 79: 331337, 1985
  • 45
    Willkens RF, Leonard PA, Clegg DO, Tolman KG, Ward JR, Marks CR, Greene ML, Roth GJ, Jackson CG, Cannon GW, Lee RG: Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis. Ann Rheum Dis 49: 591593, 1990
  • 46
    Shergy WJ, Polisson RP, Caldwell DS, Rice JR, Pisetsky DS, Allen NB: Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis. Am J Med 85: 771774, 1988
  • 47
    Kremer JM: Long-term prospective sequential liver biopsies in patients with rheumatoid arthritis on weekly oral methotrexate (abstract). Arthritis Rheum 33 (suppl 9): S40, 1990
  • 48
    Aponte J, Petrelli M: Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate. Arthritis Rheum 31: 14571464, 1988
  • 49
    Tolman KG, Clegg DO, Lee RG, Ward JR: Methotrexate and the liver. J Rheumatol 12 (Suppl): 2934, 1985
  • 50
    Szanto E, Sandstedt B, Kollberg B: Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis. Scand J Rheumatol 16: 229234, 1987
  • 51
    Sawitzke AD, Jackson CG, Lundberg ML, Clegg DO, Williams HJ, Tolman KG, Ward JR: Serial liver biopsies from methotrexate-treated rheumatoid arthritis patients (abstract). Arthritis Rheum 34 (suppl 9): S161, 1991
  • 52
    Kremer JM, Kaye GI: Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis: correlation with light microscopic findings. Arthritis Rheum 32: 12021213, 1989
  • 53
    Clegg DO, Furst DE, Tolman KG, Pogue R: Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis. J Rheumatol 16: 11231126, 1989
  • 54
    Kujala GA, Shamma'a JM, Chang WL, Brick JE: Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate. Arthritis Rheum 33: 10371041, 1990
  • 55
    Augur NA, Anderson LG, Cogen L, Miller M, Morton GL: Prospective study of hepatotoxicity in patients receiving methotrexate for rheumatoid arthritis (abstract). Arthritis Rheum 33 (suppl 9): S60, 1990
  • 56
    Walker AM, Funch D, Dreyer NA, Tolman KG, Kremer JM, Alarcón GS, Lee RG, Weinblatt ME: Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis Rheum 36: 329335, 1993
  • 57
    Whiting-O'Keefe QE, Fye KH, Sack KD: Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med 90: 711716, 1991
  • 58
    Weinstein GD, Roenigk H, Maibach HI, Weinstein G, Cosmides J, Halperin K, Millard M: Psoriasis-liver-methotrexate interactions. Arch Dermatol 108: 3642, 1973
  • 59
    Nyfors A: Liver biopsies from psoriatics related to methotrexate therapy: 3. Findings in post-methotrexate liver biopsies from 160 psoriatics. Acta Pathol Microbiol Scand [A] 85: 511518, 1977
  • 60
    Zachariae H, Kragballe K, Sogaard H: Methotrexate induced liver cirrhosis: studies including serial liver biopsies during continued treatment. Br J Dermatol 102: 407412, 1980
  • 61
    Garcia-Tsao G, Boyer JL: Outpatient liver biopsy: how safe is it? Ann Intern Med 118: 150153, 1993
  • 62
    Bergquist SR, Felson DT, Freedberg KA: The cost-effectiveness of liver biopsy in rheumatoid arthritis patients on methotrexate (abstract). Arthritis Rheum 36 (suppl 5): R32, 1993
  • 63
    Piccinno F, Sagnelli E, Pasquale G, Giusti G: Complications following percutaneous liver biopsy: a multicentre retrospective study on 68,276 biopsies. J Hepatol 2: 165173, 1986